Detalhe da pesquisa
1.
NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study.
Gut
; 68(8): 1396-1405, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30448772
2.
Transglutaminase-based chemo-enzymatic conjugation approach yields homogeneous antibody-drug conjugates.
Bioconjug Chem
; 25(3): 569-78, 2014 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24483299
3.
Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor control.
Open Res Eur
; 1: 107, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35967081
4.
An Anti-MICA/B Antibody and IL-15 Rescue Altered NKG2D-Dependent NK Cell Responses in Hepatocellular Carcinoma.
Cancers (Basel)
; 12(12)2020 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33266137